<DOC>
	<DOCNO>NCT02128555</DOCNO>
	<brief_summary>The purpose TARVA determine whether Total Ankle Replacement ( TAR ) provide well clinical outcome ankle arthrodesis patient age 50-85 year end-stage ankle osteoarthritis , compare cost-effectiveness two treatment</brief_summary>
	<brief_title>Total Ankle Replacement Versus Arthrodesis Trial</brief_title>
	<detailed_description>This randomise , multi-centre , non-blinded , prospective , parallel-group trial TAR versus ankle arthrodesis patient end-stage ankle osteoarthritis ( OA ) age 50 85 year , compare clinical outcome ( pain-free function , quality life ( QoL ) , range motion ( ROM ) , rate post-procedural complication ) cost-effectiveness . TARVA clinician-led , pragmatic , superiority trial design compare improvement pain-free function , assess Manchester-Oxford Foot Questionnaire ( MOXFQ ) walking/standing domain score pre-op 52 week post-op surgical treatment group . A total 328 patient randomly allocate equal basis one two surgical treatment : ) Total Ankle Replacement ; ii ) Ankle Arthrodesis . Randomisation stratify surgeon presence OA two adjacent joint determine pre-operative MRI scan .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Diagnosis endstage ankle osteoarthritis Aged 5085 year inclusive The surgeon believe patient suitable TAR arthrodesis ( consider deformity , stability , bone quality , soft tissue envelope , neurovascular status ) The patient able read understand Patient Information Sheet ( PIS ) trial procedures The patient willing able provide write informed consent Previous ipsilateral talonavicular , subtalar calcaneocuboid fusion surgery plan within 1 year index procedure More 4 low limb joint fuse ( include contralateral limb , exclude proximal interphalangeal joint fusion ) â€¢ Unable MRI/CT scan ( e.g . severe claustrophobia contraindication either scan ) History local bone joint infection Any comorbidity , , opinion investigator , severe enough ; interfere patient 's ability complete study assessment ; present unacceptable risk patient 's safety Participant another clinical trial would materially impact participation study</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>ankle arthritis</keyword>
	<keyword>osteoarthritis</keyword>
	<keyword>total ankle replacement</keyword>
	<keyword>arthrodesis</keyword>
	<keyword>quality life</keyword>
	<keyword>musculoskeletal</keyword>
</DOC>